Clinical Trial Update: Phase 1 Study of PF-08046033 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Pfizer is evaluating PF-08046033 in a Phase 1 trial for adults with advanced solid tumors, including non-small cell lung cancer, esophageal cancer, and cutaneou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Esophageal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• PF-08046033 (PF-08046033)

Snippet

Sponsor: Pfizer | Conditions: Non-Small-Cell Lung, Esophageal Cancer | Phase 1 | Status: RECRUITING